Retraction: Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies

Juan Manuel Galdopórpora; María Victoria Olivera; Angelina Ibar; Darío Hernán Farriol; Martín Federico Desimone; Cynthia Melisa Melián Queirolo; Helena Pardo; María Victoria Tuttolomondo

doi:10.37349/eds.2025.100896

Juan Manuel Galdopórpora ¹ ,

María Victoria Olivera ² ,

Angelina Ibar ³ ,

Darío Hernán Farriol ³ ,

Martín Federico Desimone ^4,5

Cynthia Melisa Melián Queirolo ^5,6 ,

Helena Pardo ⁷

María Victoria Tuttolomondo ^4,5*

Explor Drug Sci. 2025;3:100896 DOI: https://doi.org/10.37349/eds.2025.100896

Received: Accepted: Published: March 17, 2025

Retraction to “Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies” by Galdopórpora JM, Olivera MV, Ibar A, Farriol DH, Desimone MF, Queirolo CMM, et al. Explor Drug Sci. 2025;3:100895. DOI: 10.37349/eds.2025.100895

The original article has been retracted by the authors. After the article was published, concerns were raised by one of the authors regarding their prior consent to the submission. According to journal policy, the corresponding author is responsible for ensuring that all authors agree to the submission. The corresponding author was therefore contacted for clarification. The corresponding author acknowledged that prior consent for submission had not been obtained from some of the authors due to an internal miscommunication and misunderstanding within the authors’ research group, and requested the retraction of the article. Authors Darío Hernán Farriol, Martín Federico Desimone, and Cynthia Melisa Melián Queirolo agree with the decision to retract. Authors Juan Manuel Galdopórpora, María Victoria Olivera, Angelina Ibar, and Helena Pardo could not be reached as of publication.

This retraction was approved by the Editor-in-Chief.